Europe Radioactive Tracers Market Forecast to 2028 - Regional Analysis by Test Type, End User, Tracer Type, and Application

Description

List of Tables

The Europe radioactive tracers market size is expected to grow from US$ 4,175.25 million in 2022 to US$ 11,005.25 million by 2028; it is estimated to register a CAGR of 17.5% from 2023 to 2028. The rising prevalence of chronic diseases and increased use of nuclear imaging techniques are the key factors driving the growth of the Europe radioactive tracers market.

A radioactive tracer is a chemical compound in which one or more atoms are replaced by a radioisotope. Radiotracers can be used to study chemical reactions based on the monitoring of their radioactive decay. They are also used to visualize flow in techniques such as single photon emission computed tomography (SPECT), positron emission tomography (PET), and computed radioactive particle tracking (CARPT).

Use of Radioactive Tracers in Cancer Diagnostics to Drive Growth of Europe Radioactive Tracers Market in Near Future

Oncology is one of the significantly developing fields in the healthcare sector as the number of cancer cases is increasing worldwide. According to the Institute for Health Metrics and Evaluation (IHME), cancer is the second leading cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with noticeable developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used for the accurate diagnosis of various cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, thereby providing an accurate diagnosis of cancer type. Tracers also help determine the development stage of cancer, which enables effective treatment and allow faster recovery in most cases.

Nuclear imaging techniques such as PET and SPECT use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which the diagnostic images can be generated properly. For instance, the most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active, and they need more energy, i.e., extra glucose compared to normal cells. An imaging device such as PET or SPECT is used to detect this energy release with the use of FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the body of patients so that the treatment can be tailored according to the type and stage of cancer.

Many market players and research institutes operating in the Europe radioactive tracers market are developing advanced technologies to expand their product portfolios and increase their market shares. The rising number of diagnostic procedures, product approvals, and collaborations are among the factors driving the Europe radioactive tracers market size.

A few of the recent developments in Europe radioactive tracers market are mentioned below:

In November 2022, Curium resumed Mo-99 Production with a plan of supplying its customers with molybdenum-99 (Mo-99) and technetium-99m (Tc-99m) generators. Mo-99 is critically important for the 40 million patients a year who undergo Tc-99m based SPECT scans to diagnose life-critical diseases.

In June 2022, Telix Pharmaceuticals Limited has advanced a partnership with Invicro LLC to develop an artificial intelligence (AI) platform to accompany Telix's PSMA-PET imaging agent, Illuccix (kit for the preparation of gallium Ga 68 gozetotide) - known as TelixAI. Through its solutions, conferring advanced analysis capabilities, TelixAI seeks to increase the efficiency and reproducibility of clinicians' imaging assessments, with an initial focus on prostate cancer diagnosis.

In May 2022, ImaginAb Inc. announced an agreement with Invicro LLC to supply clinical doses of ImaginAb's investigational CD8 ImmunoPET agent for use in clinical trials as part of Invicro's global core lab imaging service. The agreement also allows Invicro to produce zirconium Zr 89 crefmirlimab for its preclinical offerings.

In June 2021, IBA launched versatile high-energy new cyclotron-the Cyclone IKON-which offers the largest energy spectrum for PET and SPEC isotopes from 13 MeV to 30 MeV. IBA has redesigned its previous model, Cyclone 30 MeV, and created a next-generation system, the Cyclone IKON. It is more compact and versatile than ever and is capable of working over a large energy span with full current capacity to enable the large-scale and high-purity production of emerging PET isotopes, SPECT isotopes, and parent isotopes.

These developments are responsible for growth of Europe radioactive tracers market.

The World Health Organization (WHO), University of Missouri Research Reactor Center, and Center for Disease Control and Prevention are a few of the major primary and secondary sources referred to while preparing the report on the Europe radioactive tracers market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe radioactive tracers market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe radioactive tracers market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global neurotoxin market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00029871

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Radioactive Tracer Market - by Test Type
- 1.3.2 Europe Radioactive Tracer Market - By End User
- 1.3.3 Europe Radioactive Tracer Market - By Tracer Type
- 1.3.4 Europe Radioactive Tracer Market - By Application
- 1.3.5 Europe Radioactive Tracer Market - By Country

2. Europe Radioactive Tracer Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Radioactive Tracer Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Experts' Opinion

5. Radioactive Tracer Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Chronic Diseases
- 5.1.2 Increased Use Of Nuclear Imaging Techniques
5.2 Market Restraints
- 5.2.1 Short Shelf-Life of Radioactive Tracers
- 5.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
5.3 Market Opportunities
- 5.3.1 New Initiatives for Radioactive Tracer R&D
5.4 Future Trends
- 5.4.1 Use of Radioactive Tracers in Cancer Diagnosis
5.5 Impact Analysis

6. Europe Radioactive Tracer Market Analysis

6.1 Europe Radioactive Tracer Market Revenue Forecast and Analysis
- 6.1.1 Market Positioning of Key Players in Radioactive Tracer Market

7. Europe Radioactive Tracer Market Analysis - by Test Type

7.1 Overview
7.2 PET
- 7.2.1 Overview
- 7.2.2 PET: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
7.3 SPECT
- 7.3.1 Overview
- 7.3.2 SPECT: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Radioactive Tracer Market Analysis - by End User

8.1 Overview
8.2 Hospitals and Clinics
- 8.2.1 Overview
- 8.2.2 Hospitals and Clinics: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
8.3 Diagnostic Centers
- 8.3.1 Overview
- 8.3.2 Diagnostic Center: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Academic and Research Institute
- 8.4.1 Overview
- 8.4.2 Academic and Research Institute: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Radioactive Tracer Market Analysis - by Tracer Type

9.1 Overview
9.2 Technetium-99m And Tc-97m
- 9.2.1 Overview
- 9.2.2 Technetium-99m And Tc-97m: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.2.3 Technetium-99m And Tc-97m: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.3 IODINE-131
- 9.3.1 Overview
- 9.3.2 IODINE-131: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.3 IODINE-13: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.4 IRON-59
- 9.4.1 Overview
- 9.4.2 IRON-59: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4.3 IRON-59: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.5 LUTETIUM-171
- 9.5.1 Overview
- 9.5.2 LUTETIUM-171: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5.3 LUTETIUM-171: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.6 Rubidium (Rb-82) Chloride and Ammonia (N-13)
- 9.6.1 Overview
- 9.6.2 Rubidium (Rb-82) Chloride and Ammonia (N-13): Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.6.3 Rubidium (Rb-82) Chloride and Ammonia (N-13): Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.7 Scandium-46
- 9.7.1 Overview
- 9.7.2 Scandium-46: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.7.3 Scandium-46: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.8 Seaborgium-269
- 9.8.1 Overview
- 9.8.2 Seaborgium-269: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.8.3 Seaborgium-269: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.9 Hassium-269
- 9.9.1 Overview
- 9.9.2 Hassium-269: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.9.3 Hassium-269: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.10 Gallium Citrate Ga 67
- 9.10.1 Overview
- 9.10.2 Gallium Citrate Ga 67: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.10.3 Gallium Citrate Ga 67: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.11 Prostate-specific membrane antigen (PSMA) (Ga-68)
- 9.11.1 Overview
- 9.11.2 Prostate-specific membrane antigen (PSMA) (Ga-68): Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.11.3 Prostate-specific membrane antigen (PSMA) (Ga-68): Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.12 FDDNP (F-18) and FDOPA (F-18)
- 9.12.1 Overview
- 9.12.2 FDDNP (F-18) and FDOPA (F-18): Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.12.3 FDDNP (F-18) and FDOPA (F-18): Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.13 Phosphorus-32 and chromium-51
- 9.13.1 Overview
- 9.13.2 Phosphorus-32 and chromium-51: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.13.3 Phosphorus-32 and chromium-51: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.14 Thallium-201
- 9.14.1 Overview
- 9.14.2 Thallium-201: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.14.3 Thallium-201: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.15 F-18 FDG
- 9.15.1 Overview
- 9.15.2 F-18 FDG: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.15.3 F-18 FDG: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.16 F-18 FAPI
- 9.16.1 Overview
- 9.16.2 F-18 FAPI: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.16.3 F-18 FAPI: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.17 GA-68 FAPI
- 9.17.1 Overview
- 9.17.2 GA-68 FAPI: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.17.3 GA-68 FAPI: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.18 F-18 PSMA
- 9.18.1 Overview
- 9.18.2 F-18 PSMA: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.18.3 F-18 PSMA: Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.19 Ga-68 (DOTATOC/DOTANOC/ DOTATATE)
- 9.19.1 Overview
- 9.19.2 GA-68 (DOTATOC/DOTANOC/ DOTATATE) : Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 9.19.3 GA-68 DOTATOC/DOTANOC/ DOTATATE): Europe Radioactive Tracer Market - Volume and Forecast to 2028
9.20 Others Tracer
- 9.20.1 Overview
- 9.20.2 Other Tracer Element: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Radioactive Tracer Market Analysis - by Application

10.1 Overview
10.2 Oncology
- 10.2.1 Overview
- 10.2.2 Oncology: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
10.3 Pulmonary
- 10.3.1 Overview
- 10.3.2 Pulmonary: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Neurology
- 10.4.1 Overview
- 10.4.2 Neurology: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Cardiology
- 10.5.1 Overview
- 10.5.2 Cardiology: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)

11. Europe Radioactive Tracer Market

11.1 Europe
- 11.1.1 Overview
- 11.1.2 Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
- 11.1.3 Europe Radioactive Tracer Market, by Test Type, 2019-2028 (US$ Million)
- 11.1.4 Europe Radioactive Tracer Market, by End User, 2019-2028 (US$ Million)
- 11.1.5 Europe Radioactive Tracer Market, by Tracer Type, 2019-2028 (US$ Million)
- 11.1.6 Europe Radioactive Tracer Market, by Tracer Type, 2019-2028 (Unit)
- 11.1.7 Europe Radioactive Tracer Market, by Application, 2019-2028 (US$ Million)
- 11.1.8 Europe Radioactive Tracer Market, by Country, 2021 & 2028 (%)
  - 11.1.8.1 Germany
    - 11.1.8.1.1 Overview
    - 11.1.8.1.2 Germany Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.8.1.3 Germany Radioactive Tracer Market, by Test Type, 2019-2028 (US$ Million)
    - 11.1.8.1.4 Germany Radioactive Tracer Market, by End User, 2019-2028 (US$ Million)
    - 11.1.8.1.5 Germany Radioactive Tracer Market, by Tracer Type, 2019-2028 (US$ Million)
    - 11.1.8.1.6 Germany Radioactive Tracer Market, by Tracer Type, 2019-2028 (Unit)
    - 11.1.8.1.7 Germany Radioactive Tracer Market, by Application Type, 2019-2028 (US$ Million)
  - 11.1.8.2 United Kingdom
    - 11.1.8.2.1 Overview
    - 11.1.8.2.2 United Kingdom Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.8.2.3 United Kingdom Radioactive Tracer Market, by Test Type, 2019-2028 (US$ Million)
    - 11.1.8.2.4 United Kingdom Radioactive Tracer Market, by End User, 2019-2028 (US$ Million)
    - 11.1.8.2.5 United Kingdom Radioactive Tracer Market, by Tracer Type, 2019-2028 (US$ Million)
    - 11.1.8.2.6 United Kingdom Radioactive Tracer Market, by Tracer Type, 2019-2028 (Unit)
    - 11.1.8.2.7 United Kingdom Radioactive Tracer Market, by Application Type, 2019-2028 (US$ Million)
  - 11.1.8.3 France
    - 11.1.8.3.1 Overview
    - 11.1.8.3.2 France Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.8.3.3 France Radioactive Tracer Market, by Test Type, 2019-2028 (US$ Million)
    - 11.1.8.3.4 France Radioactive Tracer Market, by End User, 2019-2028 (US$ Million)
    - 11.1.8.3.5 France Radioactive Tracer Market, by Tracer Type, 2019-2028 (US$ Million)
    - 11.1.8.3.6 France Radioactive Tracer Market, by Tracer Type, 2019-2028 (Unit)
    - 11.1.8.3.7 France Radioactive Tracer Market, by Application Type, 2019-2028 (US$ Million)
  - 11.1.8.4 Italy
    - 11.1.8.4.1 Overview
    - 11.1.8.4.2 Italy Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.8.4.3 Italy Radioactive Tracer Market, by Test Type, 2019-2028 (US$ Million)
    - 11.1.8.4.4 Italy Radioactive Tracer Market, by End User, 2019-2028 (US$ Million)
    - 11.1.8.4.5 Italy Radioactive Tracer Market, by Tracer Type, 2019-2028 (US$ Million)
    - 11.1.8.4.6 Italy Radioactive Tracer Market, by Tracer Type, 2019-2028 (Unit)
    - 11.1.8.4.7 Italy Radioactive Tracer Market, by Application Type, 2019-2028 (US$ Million)
  - 11.1.8.5 Spain
    - 11.1.8.5.1 Overview
    - 11.1.8.5.2 Spain Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.8.5.3 Spain Radioactive Tracer Market, by Test Type, 2019-2028 (US$ Million)
    - 11.1.8.5.4 Spain Radioactive Tracer Market, by End User, 2019-2028 (US$ Million)
    - 11.1.8.5.5 Spain Radioactive Tracer Market, by Tracer Type, 2019-2028 (US$ Million)
    - 11.1.8.5.6 Spain Radioactive Tracer Market, by Tracer Type, 2019-2028 (Unit)
    - 11.1.8.5.7 Spain Radioactive Tracer Market, by Application Type, 2019-2028 (US$ Million)
  - 11.1.8.6 Rest of Europe
    - 11.1.8.6.1 Overview
    - 11.1.8.6.2 Rest of Europe Radioactive Tracer Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.8.6.3 Rest of Europe Radioactive Tracer Market, by Test Type, 2019-2028 (US$ Million)
    - 11.1.8.6.4 Rest of Europe Radioactive Tracer Market, by End User, 2019-2028 (US$ Million)
    - 11.1.8.6.5 Rest of Europe Radioactive Tracer Market, by Tracer Type, 2019-2028 (US$ Million)
    - 11.1.8.6.6 Rest of Europe Radioactive Tracer Market, by Tracer Type, 2019-2028 (Unit)
    - 11.1.8.6.7 Rest of Europe Radioactive Tracer Market, by Application Type, 2019-2028 (US$ Million)

12. Europe Radioactive Tracer Market: Impact Assessment of COVID-19 Pandemic

12.1 Impact Analysis of COVID-19 Pandemic on Europe Radioactive Tracer Market

13. Europe Radioactive Tracers Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Europe Radioactive Tracers Market (%)
13.3 Inorganic Developments
- 13.3.1 Overview
13.4 Organic Developments
- 13.4.1 Overview

14. Company Profiles

14.1 Rotem Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 ABX advanced biochemical compounds GmbH
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Invicro LLC
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cardinal Health Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Newcastle University
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Novartis AG
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Curium
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Blue Earth Diagnostics Limited
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 General Electric Co
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 IBA Radiopharma Solutions
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms